Rare Diseases
Conference Coverage
Hold the central lymph node dissection for small parathyroid tumors?
Key clinical point: Central lymph node dissection may not be needed for patients with small parathyroid tumors.Major finding: In a multivariate...
News
ESMO updates practice guidelines for bladder cancer
News
Novel antimetabolite strategy slows progression of deadly mesothelioma
Key clinical point: An antimetabolite strategy that cuts off the supply of arginine to tumors may benefit patients with mesothelioma.Major finding...
News
Angiogenic kinase inhibitor receives orphan drug designation for hepatocellular carcinoma
Conference Coverage
Liver cancer without cirrhosis surprisingly common: Is NAFLD the cause?
Key clinical point: A significant proportion of NAFLD-related HCC patients have no cirrhosis at presentation, so clinicians need to maintain a...
News
Launch of rare-cancer trial spurs many more
News
Bevacizumab fails to improve survival in newly diagnosed glioblastoma
Major finding: Two similar studies found no difference in median survival with the addition of bevacizumab to standard therapy for patients with...
News
MicroRNA screening might reveal pancreatic cancer
Major finding: Two panels of microRNAs correctly diagnosed pancreatic cancer in 85% of affected patients and correctly diagnosed chronic...
Conference Coverage
New chemo regimen is active against recalcitrant neuroendocrine tumors
Major finding: The overall response rate was 43% and the clinical benefit rate was 97%. Data source: A randomized phase II trial among 28 patients...
News
Gene panel identifies residual neuroblastoma metastases
Major finding: In a multivariate analysis, patients negative for minimal residual disease had about a fourfold increased rate of progression-free...
Conference Coverage
Resurrected gemtuzumab shows benefit against pediatric AML
Major finding: Three-year event-free survival rates were 53% for children and young adults treated with gemtuzumab ozogamicin added to a standard...